{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreiasgmgwfs55odpjue5etcrwtulecgk5yfapzy72rxco47tncvbyja",
    "uri": "at://did:plc:amgpmo7quvdl4rzvmmjibtx6/app.bsky.feed.post/3mkxx4ekqisi2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreibxbrp4gd4j56cdtlevmgah4vasbubwfvv55xltpf4hewqqsx4gj4"
    },
    "mimeType": "image/jpeg",
    "size": 595488
  },
  "path": "/2026/05/03/science/ibogaine-psychedelics-rogan-trump.html",
  "publishedAt": "2026-05-03T09:00:52.000Z",
  "site": "https://www.nytimes.com",
  "tags": [
    "United States Politics and Government",
    "Psychedelic and Hallucinogenic Drugs",
    "Drug Abuse and Traffic",
    "Conservatism (US Politics)",
    "Mental Health and Disorders",
    "Alternative and Complementary Medicine",
    "Veterans",
    "Politics and Government",
    "Recalls and Bans of Products",
    "Nineteen Hundred Sixties",
    "Post-Traumatic Stress Disorder",
    "Drugs (Pharmaceuticals)",
    "Anxiety and Stress",
    "Therapy and Rehabilitation",
    "Multidisciplinary Assn for Psychedelic Studies",
    "Trump, Donald J",
    "Rogan, Joe"
  ],
  "textContent": "For decades, conservatives were adamantly opposed to the use of drugs like psilocybin and LSD. Now, the Trump administration has made a sharp pivot.",
  "title": "A Long, Strange Trip: How the G.O.P. Came to Embrace Psychedelic Drugs"
}